A new isocratic HPLC method, employing electrochemical detection, is described for the determination of urinary vanillylmandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid. The main advantages of this technique are: simplicity, simultaneous determination of all analytes, the absence of an extraction procedure, isocratic elution and low cost. The diluted urine is injected onto a CIS reversed phase column. The mobile phase is potassium dihydrogenphosphate buffer containing 1-heptanesulphonic acid, methanol and acetonitrile. The calibration curves are linear from 0.1 to 50 mg/1; the precision data show CV less than 2.36% for within-day assay and less than 2.72% for day-to-day assays. The mean recoveries for supplemented samples are 98.2 to 102.0% for vanillylmandelic acid, 99.6 to 103.9% for 5-hydroxyindoleacetic acid and 98.7 to 102.0% for homovanillic acid. In comparisons of the present method with Radjaipur's extraction method (Radjaipur M. et al., Eur J Clin Chem Clin Biochem 1994; 32:609-13) the slopes for the three analytes were nearly 1, and the confidence region of the intercepts was close to 0. In conclusion the technique seems to be suitable for routine determination of the three analytes, especially for mass screening purposes.
Introduction
Vanillylmandelic acid (4-hydroxy-3-methoxymandelic acid) and homovanillic acid (4-hydroxy-3-methoxy-phenylacetic acid), the major metabolites of catecholamines, and 5-hydroxyindoleacetic acid (5-hydroxy-3-indoleacetic acid), metabolite of serotonin, are often determined in urine for neurologic diagnosis and for monitoring the response to therapy in illnesses like phaeochromocytoma, neuroblastoma and carcinoid syndrome, respectively (1,2).
High-performance liquid Chromatographie (HPLC) methods for vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid have been reported, either without (3 -13) or with (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) simultaneous determination of all three analytes. Combined analysis was proposed mainly for technical reasons, but the molecular characteristics of these metabolites also conveniently enable their simultaneous determination in a single HPLC run. However none of these techniques is totally free of technical problems, and the time of operation and high cost are still matters of concern. For instance many methods need an extraction step or sample pretreatment (14) (15) (16) (17) (18) (19) (20) (21) (22) 24) : some determinations require gradient elution techniques and an excessive time for regeneration of the column after each run (14, 17, 18, 23, 24) ; in addition, some of these methods employ time-consuming procedures and/or need instrumentation not always available in a clinical laboratory (15, (18) (19) (20) .
In this work we describe our new simultaneous HPLC technique, developed for an isocratic separation and quantitation of vanillylmandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid in urine, using a reversed phase column and an electrochemical detector.
Materials and Methods

Patients
Urine samples were collected early in the morning from adult volunteers who did not consume walnuts, vegetable food, coffee, bananas and food containing vanilla after 1 p. m. of the previous day. In assessing the reliability of our method we expressed the concentrations of these metabolites in μηιοΐ/ΐ, rather than μιηοΐ of compound per g creatinine which is used in routine analyses (19) . Urine was stored at -20 °C after acidification with 6 mol/1 hydrochloric acid to a pH of about 4. Under these conditions vanillylmandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid are stable for at least four weeks (7).
Reagents
All reagents and chemicals were of analytical grade and were purchased from Carlo Erba (Milan, Italy) except for vanillylmandelic acid, 5-hydroindoleacetic acid, homovanillic acid and 1-heptanesulphonic acid which were from Sigma (St. Louis, MO, USA). Methanol and water, both of HPLC grade, were obtained from Merck (Darmstadt, Germany).
Apparatus
A model 116 Beckman (Palo Alto, CA, USA) pump, a Rheodyne (Berkeley, CA, USA) Model 7125 injector and a HP 3395 Integrator (Hewlett-Packard, Les Ulis, France) were used. We employed an ES A electrochemical detector Model 5110 Coulochem (Environmental Sciences Assoc. Bedford, MA, USA) with a Model 5011 analytical cell. Separation was carried out with a Supelcosil LC 18 DB 150 X 4.6 mm i.d. column (3-μηι particle size) fitted with a 20 X 4.6 mm guard column (both from Supelco, Oakville, Canada).
Standards
A stock solution (500 mg/1 each of vanillylmandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid) was prepared by dissolving 50 mg of each compound in mobile phase and adjusting the volume to 100 ml. This was divided into several aliquots and frozen at -20 °C; under these conditions the stock solution is stable for at least 4 weeks and the working standards were prepared by diluting it with mobile phase.
Mobile phase
The mobile phase is a mixture of 990 ml of 35 mmol/1 potassium dihydrogenphosphate buffer containing 100 mg/1 of 1-heptanesul-phonic acid as the ion-pair agent to reduce the interferences in the analysis (20) and 5 ml of methanol and 5 ml of acetonitrile to shorten the retention times; the pH of the solution was adjusted to 2.8 with phosphoric acid. Prior to use the phase was degassed and filtered through a 0.45 μηι MF Millipore filter.
Samples
Intact urine (100 μΐ) was added to another tube containing 4.9 ml of mobile phase; 100 μΐ of this vortexed mixture was immediately injected into the Chromatograph. When the urine sample contained insoluble impurities, the assay was performed using the supernatant after centrifugation (200 g, 5 min).
High performance liquid chromatography conditions
Diluted sample (100 μΐ) was injected into the HPLC. The flow rate for the isocratic elution was set at 1.0 ml/min and the column was maintained at room temperature. Since 5-hydroxyindoleacetic acid oxidizes much more easily than vanillylmandelic acid and homovanillic acid, the electroactive compounds were analysed electro- 
Determination of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid by an extraction method
For the method comparison we analysed 30 urine samples using our method and Radjaipur's extraction method (20) . Vanillylmandelic Acid, homovanillic acid and 5-hydroxyindoleacetic acid were extracted from urine samples using a cation exchange column (Pharmacia-LKB Freiburg, Germany) to remove neutral, basic, weakly acidic sample components and proteins. Coefficients of variation less than 2.36% for within-day and less than 2.72% for day-to-day were obtained. Linearity was studied by adding known amounts of the three acids (5, 10 and 20 mg/1) to two human urine pool samples (normal and pathological levels) on three different occasions. Results: vanillylmandelic acid r > 0.998, 5-hydroxyindoleacetic acid r > 0.997, homovanillic acid r > 0.997. Detection limits were below 0.1 mg/1 for all three metabolites at a signal-to-noise ratio of 3. Recovery was assessed from replicate analysis (n = 5) for two days by adding 5 mg/1 and 20 mg/1 of vanillylmandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid to normal and pathological urine pool samples respectively (tab. 2). Figure 2 reports the comparison between vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid concentrations calculated by the present method and by Radjaipur's extraction method; the data of the regression analysis are reported in table 3. The slopes of the three analytes were close to 1, and the confidence region of the intercepts were close to 0. Then we evaluated potential interference from common urine constituents and drugs, which may be eluted close to the peaks of interest (16) , by adding known amounts of these to the urine samples. None of the tested compounds (epinephrine, serotonin, vanillic acid, uric acid, ascorbic acid, acetaminophen, Z--DOPA, carbi-DOPA and acetylsalicylic acid) showed substantial interference with the determination of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid, because they gave recoveries < 0.1% or no peak at all.
Discussion
Clinical diagnosis of some neurological disorders needs precise, rapid and simple determination of catecholamine metabolites and 5-hydroxyindoleacetic acid in urine. Low-cost methods are necessary to satisfy the rising demand for mass screening in childhood (26) (27) (28) (29) (30) . In view of its analytical characteristics, our technique could represent a new solution to these requests. The key advantage of this method is the ability of ion-pair chromatography (heptanesulphonic acid is added in the mobile phase) to reduce interference by a large number of compounds commonly observed in urine (20) . The use of ion-pair chromatography and the above mentioned HPLC conditions resulted in clean peaks of these three substances; the extraction step was avoided without losing precision, accuracy and linearity. Although no interferences have been shown in our study, we think that a further investigation of the influence of dietary components is needed to confirm its specificity. However the combination of all these characteristics ensures good reliability. In conclusion our HPLC method is very fast, easy and inexpensive and requires an apparatus easily accessible to all clinical laboratories equipped with HPLC instrumentation, and it is certainly useful for routine determination and for mass screening for neurological impairment.
